Hillerød, Denmark

Søren Møller Nielsen


 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Søren Møller Nielsen

Introduction

Søren Møller Nielsen is a prominent inventor based in Hillerød, Denmark. With an impressive portfolio of three patents, he has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for the treatment of psychosis and schizophrenia.

Latest Patents

Nielsen's latest patents include innovative compounds that serve as NK3 antagonists. One notable patent focuses on isoquinolinone derivatives, which are described as useful for addressing psychosis and schizophrenia. The isoquinolone derivatives of the general formula I provide a potential pathway for new therapeutic options. Another significant patent centers on pyridone derivatives, which are similarly valuable in therapeutic applications, specifically targeting psychosis and related diseases. These compounds promise advancements in treatment methodologies, highlighting Nielsen's commitment to developing novel medical solutions.

Career Highlights

Søren Møller Nielsen currently works at H. Lundbeck A/S, a renowned pharmaceutical company known for its dedication to improving the quality of life for those suffering from brain disorders. His work at Lundbeck emphasizes the importance of innovative research in developing effective treatments for complex psychiatric conditions. Nielsen's dedication to his craft is evident in the quality and impact of his patented inventions.

Collaborations

Throughout his career, Søren has collaborated with talented colleagues, including Nikolay Khanzhin and Karsten Juhl. These collaborations foster an environment of shared knowledge and expertise, contributing to the innovative spirit at H. Lundbeck A/S.

Conclusion

Søren Møller Nielsen stands out as an influential figure in the field of medicinal chemistry, with his inventive contributions paving the way for advancements in the treatment of mental health disorders. His ongoing work and collaborations underscore the importance of innovation in developing effective therapeutic agents and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…